Use of Ethanol Extracts of Terminalia Chebula to Prevent Periodontal Disease Induced by Dental Plaque Bacteria

Overview

Journal BMC Complement Altern Med

Publisher Biomed Central

Specialty Rehabilitation Medicine

Date 2017 Feb 17

PMID 28202081

Citations 10

Authors

Jongsung Lee

Youn Hwa Nho

Seok Kyun Yun

Young Sun Hwang

Affiliations

Soon will be listed here.

Abstract

Background: The fruit of the Terminalia chebula tree has been widely used for the treatment of various disorders. Its anti-diabetic, anti-mutagenic, anti-oxidant, anti-bacterial, anti-fungal, and anti-viral effects have been studied. Dental plaque bacteria (DPB) are intimately associated with gingivitis and periodontitis. In the quest for materials that will prove useful in the treatment and prevention of periodontal disease, we investigated the preventive effects of an ethanol extract of Terminalia chebula (EETC) on DPB-induced inflammation and bone resorption.

Methods: The anti-bacterial effect of EETC was analyzed using the disc diffusion method. The anti-inflammatory effect of EETC was determined by molecular biological analysis of the DPB-mediated culture cells. Prevention of osteoclastic bone resorption by EETC was explored using osteoclast formation and pit formation assays.

Results: EETC suppressed the growth of oral bacteria and reduced the induction of inflammatory cytokines and proteases, abolishing the expression of PGE2 and COX-2 and inhibiting matrix damage. By stimulating the DPB-derived lipopolysaccharides, EETC inhibited both osteoclast formation in osteoclast precursors and RANKL expression in osteoblasts, thereby contributing to the prevention of bone resorption.

Conclusions: EETC may be a beneficial supplement to help prevent DPB-mediated periodontal disease.

Citing Articles

Exploring the therapeutic potential of medicinal plants and their active principles in dental care: A comprehensive review.

Refaey M, Abosalem E, Yasser El-Basyouni R, Elsheriri S, Elbehary S, Fayed M Heliyon. 2024; 10(18):e37641.

PMID: 39318809 PMC: 11420497. DOI: 10.1016/j.heliyon.2024.e37641.

Autoclavable Albumin-Based Cryogels with Uncompromising Properties.

Duan K, Mehwish N, Xu M, Zhu H, Hu J, Lin M Gels. 2023; 9(9).

PMID: 37754393 PMC: 10530076. DOI: 10.3390/gels9090712.

Green Alternatives as Antimicrobial Agents in Mitigating Periodontal Diseases: A Narrative Review.

Mosaddad S, Hussain A, Tebyaniyan H Microorganisms. 2023; 11(5).

PMID: 37317243 PMC: 10220622. DOI: 10.3390/microorganisms11051269.

Antimicrobial activity of Desplac® oral gel in the subgingival multispecies biofilm formation.

Bueno-Silva B, Kiausinus K, Goncalves F, Cintra Moreira M, de Oliveira E, Brugnera Junior A Front Microbiol. 2023; 14:1122051.

PMID: 37260680 PMC: 10227524. DOI: 10.3389/fmicb.2023.1122051.

Bibliometric Study of Adaptogens in Dermatology: Pharmacophylogeny, Phytochemistry, and Pharmacological Mechanisms.

Liu X, Chen C, Li L, Guo M, He Y, Meng H Drug Des Devel Ther. 2023; 17:341-361.

PMID: 36776447 PMC: 9912821. DOI: 10.2147/DDDT.S395256.

References

Yucel-Lindberg T, Bage T . Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med. 2013; 15:e7. DOI: 10.1017/erm.2013.8. View

Amarasekara D, Yu J, Rho J . Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases. J Immunol Res. 2015; 2015:832127. PMC: 4434203. DOI: 10.1155/2015/832127. View

Gupta D, Gupta R, Bhaskar D, Gupta V . Comparative evaluation of terminalia chebula extract mouthwash and chlorhexidine mouthwash on plaque and gingival inflammation - 4-week randomised control trial. Oral Health Prev Dent. 2014; 13(1):5-12. DOI: 10.3290/j.ohpd.a32994. View

Hou G, Guo C, Song G, Fang N, Fan W, Chen X . Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells. Int J Mol Med. 2013; 32(2):503-10. DOI: 10.3892/ijmm.2013.1406. View

Jiang Y, Mehta C, Hsu T, Alsulaimani F . Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun. 2002; 70(6):3143-8. PMC: 127969. DOI: 10.1128/IAI.70.6.3143-3148.2002. View

Bowden E, Coopman P, Mueller S . Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol. 2000; 63:613-27. DOI: 10.1016/s0091-679x(01)63033-4. View

Yost S, Duran-Pinedo A, Teles R, Krishnan K, Frias-Lopez J . Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis. Genome Med. 2015; 7(1):27. PMC: 4410737. DOI: 10.1186/s13073-015-0153-3. View

Pier G . Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol. 2007; 297(5):277-95. PMC: 1994162. DOI: 10.1016/j.ijmm.2007.03.012. View

Kim H, Cho J, Jeong E, Lim J, Lee S, Lee H . Growth-inhibiting activity of active component isolated from Terminalia chebula fruits against intestinal bacteria. J Food Prot. 2006; 69(9):2205-9. DOI: 10.4315/0362-028x-69.9.2205. View

10.

Zhang X, Jung I, Hwang Y . EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression. Tumour Biol. 2015; 37(2):2555-63. DOI: 10.1007/s13277-015-4099-2. View

11.

Sanz M, van Winkelhoff A, Herrera D, Simon R, Winkel E . Differences in the composition of the subgingival microbiota of two periodontitis populations of different geographical origin. A comparison between Spain and The Netherlands. Eur J Oral Sci. 2000; 108(5):383-92. DOI: 10.1034/j.1600-0722.2000.108005383.x. View

12.

Sukumar S, Roberts A, Martin F, Adler C . Metagenomic Insights into Transferable Antibiotic Resistance in Oral Bacteria. J Dent Res. 2016; 95(9):969-76. DOI: 10.1177/0022034516648944. View

13.

Miznerova E, Hlavaty T, Koller T, Toth J, Holociova K, Huorka M . The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease. Bratisl Lek Listy. 2013; 114(8):439-45. DOI: 10.4149/bll_2013_092. View

14.

Cekici A, Kantarci A, Hasturk H, Van Dyke T . Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2013; 64(1):57-80. PMC: 4500791. DOI: 10.1111/prd.12002. View

15.

Tanaka Y, Nakayamada S, Okada Y . Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy. 2005; 4(3):325-8. DOI: 10.2174/1568010054022015. View

16.

Mogensen T . Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009; 22(2):240-73, Table of Contents. PMC: 2668232. DOI: 10.1128/CMR.00046-08. View

17.

Thornton-Evans G, Eke P, Wei L, Palmer A, Moeti R, Hutchins S . Periodontitis among adults aged ≥30 years - United States, 2009-2010. MMWR Suppl. 2013; 62(3):129-35. View

18.

Madianos P, Bobetsis Y, Kinane D . Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol. 2005; 32 Suppl 6:57-71. DOI: 10.1111/j.1600-051X.2005.00821.x. View

19.

Moran A, Prendergast M, Appelmelk B . Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol Med Microbiol. 1996; 16(2):105-15. DOI: 10.1111/j.1574-695X.1996.tb00127.x. View

20.

Nakanishi M, Rosenberg D . Multifaceted roles of PGE2 in inflammation and cancer. Semin Immunopathol. 2012; 35(2):123-37. PMC: 3568185. DOI: 10.1007/s00281-012-0342-8. View